Chelsea Counsel Company’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.5K Sell
1,141
-882
-44% -$65.5K 0.03% 124
2025
Q4
$160K Sell
2,023
-6,887
-77% -$527K 0.07% 103
2025
Q3
$650K Sell
8,910
-1,685
-16% -$124K 0.29% 59
2025
Q2
$804K Buy
10,595
+9,304
+721% +$659K 0.4% 49
2025
Q1
$98.2K Sell
1,291
-25
-2% -$1.86K 0.05% 116
2024
Q4
$86.9K Hold
1,316
0.04% 113
2024
Q3
$91.8K Sell
1,316
-2
-0.2% -$120 0.05% 114
2024
Q2
$69.7K Buy
+1,318
New +$80K 0.03% 120

Other funds holding SOLV

Chelsea Counsel Company's SOLV Position: Q1 2026 in Review

Chelsea Counsel Company reduced its Solventum (SOLV) stake by 44% in Q1 2026, selling an estimated $65.5K and leaving 1,141 shares worth $74.5K. The position accounts for 0.03% of the portfolio, ranked #124.

Chelsea Counsel Company first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $804K in Q2 2025. 879 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Chelsea Counsel Company held 1,141 shares of Solventum worth $74.5K as of Q1 2026.
  • Chelsea Counsel Company sold 882 Solventum shares in Q1 2026, an estimated $65.5K.
  • Solventum made up 0.03% of Chelsea Counsel Company's portfolio in Q1 2026, its #124 holding.
  • Chelsea Counsel Company first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • Chelsea Counsel Company's Solventum position peaked at $804K in Q2 2025.
  • 879 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.